OPTIMER PHARMACEUTICALS INC Net Income (Loss) Available to Common Stockholders, Basic
OPTIMER PHARMACEUTICALS INC reported Net Income (Loss) Available to Common Stockholders, Basic of -$26.87 million for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-08-07.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2013-08-07
- OPTIMER PHARMACEUTICALS INC net income (loss) available to common stockholders, basic for the quarter ending 2013-06-30 was -$26.87M.
- OPTIMER PHARMACEUTICALS INC net income (loss) available to common stockholders, basic for the quarter ending 2013-03-31 was -$31.33M.
- OPTIMER PHARMACEUTICALS INC net income (loss) available to common stockholders, basic for the quarter ending 2012-12-31 was $1.00M, a 92.50% decline year-over-year.
- OPTIMER PHARMACEUTICALS INC net income (loss) available to common stockholders, basic for the quarter ending 2012-09-30 was -$26.77M.
- OPTIMER PHARMACEUTICALS INC net income (loss) available to common stockholders, basic for fiscal 2012 was -$36.99M, a 572.88% decline from fiscal 2011.
- OPTIMER PHARMACEUTICALS INC net income (loss) available to common stockholders, basic for fiscal 2011 was $7.82M.
- OPTIMER PHARMACEUTICALS INC net income (loss) available to common stockholders, basic for fiscal 2010 was -$47.34M.
- OPTIMER PHARMACEUTICALS INC net income (loss) available to common stockholders, basic for fiscal 2009 was -$42.09M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|---|
| 2013-06-30 | -$26.87M 10-Q · filed 2013-08-07 | -$58.20M 10-Q · filed 2013-08-07 | -$57.20M derived: sum of 3 quarters · filed 2013-08-07 | -$83.97M derived: sum of 4 quarters · filed 2013-08-07 | |
| 2013-03-31 | -$31.33M 10-Q · filed 2013-05-10 | -$30.33M derived: sum of 2 quarters · filed 2013-05-10 | -$57.10M derived: sum of 3 quarters · filed 2013-05-10 | -$57.40M derived: sum of 4 quarters · filed 2013-08-07 | |
| 2012-12-31 | $1.00M 10-K · filed 2013-03-18 | -$25.77M derived: sum of 2 quarters · filed 2013-03-18 | -$26.07M derived: sum of 3 quarters · filed 2013-08-07 | -$36.99M 10-K · filed 2013-03-18 | |
| 2012-09-30 | -$26.77M 10-K · filed 2013-03-18 | -$26.77M 10-Q · filed 2012-11-02 | -$27.07M derived: sum of 2 quarters · filed 2013-08-07 | -$37.99M 10-Q · filed 2012-11-02 | -$24.63M derived: sum of 4 quarters · filed 2013-08-07 |
| 2012-06-30 | -$296.20K 10-Q · filed 2013-08-07 | -$11.22M 10-Q · filed 2013-08-07 | $2.14M derived: sum of 3 quarters · filed 2013-08-07 | -$24.29M derived: sum of 4 quarters · filed 2013-08-07 | |
| 2012-03-31 | -$10.92M 10-Q · filed 2013-05-10 | $2.43M derived: sum of 2 quarters · filed 2013-05-10 | -$23.99M derived: sum of 3 quarters · filed 2013-05-10 | -$48.23M derived: sum of 4 quarters · filed 2013-05-10 | |
| 2011-12-31 | $13.35M 10-K · filed 2013-03-18 | -$13.07M derived: sum of 2 quarters · filed 2013-03-18 | -$37.31M derived: sum of 3 quarters · filed 2013-03-18 | $7.82M 10-K · filed 2013-03-18 | |
| 2011-09-30 | -$26.43M 10-K · filed 2013-03-18 | -$26.43M 10-Q · filed 2011-11-03 | -$50.67M derived: sum of 2 quarters · filed 2013-03-18 | -$5.53M 10-Q · filed 2012-11-02 | -$17.48M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | -$24.24M 10-K · filed 2013-03-18 | -$24.24M 10-Q · filed 2012-08-03 | $20.89M 10-Q · filed 2012-08-03 | $8.95M derived: sum of 3 quarters · filed 2013-03-18 | -$2.89M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | $45.13M 10-K · filed 2013-03-18 | $45.13M 10-Q · filed 2012-05-10 | $33.19M derived: sum of 2 quarters · filed 2013-03-18 | $21.35M derived: sum of 3 quarters · filed 2013-03-18 | |
| 2010-12-31 | -$11.95M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$23.78M derived: sum of 2 quarters · filed 2013-03-18 | -$47.34M 10-K · filed 2013-03-18 | ||
| 2010-09-30 | -$11.84M 10-Q · filed 2011-11-03 | -$35.39M 10-Q · filed 2011-11-03 | |||
| 2009-12-31 | -$42.09M 10-K · filed 2012-03-08 |